Compounding Quality Center of Excellence updates
Compounding Quality Center of Excellence

Improve your aseptic processing techniques

Register now for our Sterile Drug Compounding instructor-led training course, August 11-13, 2026, in Raleigh, N.C. Aseptic technique is critical in sterile drug compounding. Learn the fundamentals of sterile drug production by integrating aseptic processing, sterile filtration, cleanroom operations, facility cleaning and disinfection, aseptic process simulation (media fills) and environmental monitoring.

This training course and others are in collaboration with the Parenteral Drug Association.

Developing a product portfolio

Register today for our virtual discussion series session, Developing a Product Portfolio, August 25, 12-1:30 p.m. ET. Developing your portfolio can be challenging yet it is a fundamental part of starting a new outsourcing facility. Join our discussion with outsourcing facility executives and a group purchasing organization about developing a portfolio, including how to maintain and evolve a portfolio and how customer relationships and operational capacity factor into decision making.

Integrating quality

Join our next virtual discussion series session, Quality Beyond the Quality Unit, September 24, 12-1:30 p.m. ET. Integrating a robust quality system into all aspects of an outsourcing facility improves the quality of drugs and potentially reduces adverse actions at the facility. Join us for a discussion with outsourcing facility executives and consultants on how to embed quality across the organization.

Additional training opportunities

Visit the instructor-led and self-guided online training webpages for more courses. 

 

FDA’s Compounding Quality Center of Excellence aims to improve the quality of compounded drugs, especially those made at outsourcing facilities. We encourage outsourcing facilities and others to get involved with the Center of Excellence by taking our training courses, in-person and online, attending our annual conference and other activities. 


This email was sent to Esdek@podam.pl using Granicus Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo